Logo image of UDMY

UDEMY INC (UDMY) Stock Fundamental Analysis

NASDAQ:UDMY - Nasdaq - US9026851066 - Common Stock - Currency: USD

9.8  -0.3 (-2.97%)

After market: 9.7 -0.1 (-1.02%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to UDMY. UDMY was compared to 71 industry peers in the Diversified Consumer Services industry. While UDMY seems to be doing ok healthwise, there are quite some concerns on its profitability. UDMY is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year UDMY was profitable.
In the past year UDMY had a positive cash flow from operations.
In the past 5 years UDMY always reported negative net income.
In multiple years UDMY reported negative operating cash flow during the last 5 years.
UDMY Yearly Net Income VS EBIT VS OCF VS FCFUDMY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

UDMY has a worse Return On Assets (-14.08%) than 68.75% of its industry peers.
With a Return On Equity value of -43.21%, UDMY is not doing good in the industry: 65.63% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -14.08%
ROE -43.21%
ROIC N/A
ROA(3y)-16.47%
ROA(5y)-17.55%
ROE(3y)-39.54%
ROE(5y)-143.65%
ROIC(3y)N/A
ROIC(5y)N/A
UDMY Yearly ROA, ROE, ROICUDMY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -200 -400

1.3 Margins

UDMY's Gross Margin of 62.54% is fine compared to the rest of the industry. UDMY outperforms 75.00% of its industry peers.
UDMY's Gross Margin has improved in the last couple of years.
UDMY does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 62.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.88%
GM growth 5Y5.41%
UDMY Yearly Profit, Operating, Gross MarginsUDMY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

6

2. Health

2.1 Basic Checks

UDMY does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, UDMY has less shares outstanding
The number of shares outstanding for UDMY has been increased compared to 5 years ago.
UDMY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
UDMY Yearly Shares OutstandingUDMY Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
UDMY Yearly Total Debt VS Total AssetsUDMY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

UDMY has an Altman-Z score of 1.36. This is a bad value and indicates that UDMY is not financially healthy and even has some risk of bankruptcy.
UDMY's Altman-Z score of 1.36 is fine compared to the rest of the industry. UDMY outperforms 64.06% of its industry peers.
UDMY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 1.36
ROIC/WACCN/A
WACC10.67%
UDMY Yearly LT Debt VS Equity VS FCFUDMY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

UDMY has a Current Ratio of 1.27. This is a normal value and indicates that UDMY is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.27, UDMY perfoms like the industry average, outperforming 46.88% of the companies in the same industry.
UDMY has a Quick Ratio of 1.27. This is a normal value and indicates that UDMY is financially healthy and should not expect problems in meeting its short term obligations.
UDMY has a Quick ratio (1.27) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 1.27
UDMY Yearly Current Assets VS Current LiabilitesUDMY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 2305843009213693952.00% over the past year.
UDMY shows a small growth in Revenue. In the last year, the Revenue has grown by 7.92%.
UDMY shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 23.27% yearly.
EPS 1Y (TTM)2305843009213694000%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%400%
Revenue 1Y (TTM)7.92%
Revenue growth 3Y15.11%
Revenue growth 5Y23.27%
Sales Q2Q%5.48%

3.2 Future

Based on estimates for the next years, UDMY will show a very strong growth in Earnings Per Share. The EPS will grow by 97.80% on average per year.
The Revenue is expected to grow by 9.34% on average over the next years. This is quite good.
EPS Next Y170.58%
EPS Next 2Y97.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.22%
Revenue Next 2Y4.21%
Revenue Next 3Y7.31%
Revenue Next 5Y9.34%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
UDMY Yearly Revenue VS EstimatesUDMY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
UDMY Yearly EPS VS EstimatesUDMY Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 -0.2 0.4 -0.4 0.6

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 61.25, UDMY can be considered very expensive at the moment.
UDMY's Price/Earnings ratio is in line with the industry average.
UDMY's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 30.30.
A Price/Forward Earnings ratio of 22.64 indicates a rather expensive valuation of UDMY.
Compared to the rest of the industry, the Price/Forward Earnings ratio of UDMY indicates a somewhat cheap valuation: UDMY is cheaper than 60.94% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of UDMY to the average of the S&P500 Index (23.06), we can say UDMY is valued inline with the index average.
Industry RankSector Rank
PE 61.25
Fwd PE 22.64
UDMY Price Earnings VS Forward Price EarningsUDMY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of UDMY is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 37.36
EV/EBITDA N/A
UDMY Per share dataUDMY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

UDMY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
UDMY's earnings are expected to grow with 97.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.36
PEG (5Y)N/A
EPS Next 2Y97.8%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for UDMY!.
Industry RankSector Rank
Dividend Yield N/A

UDEMY INC

NASDAQ:UDMY (2/20/2025, 8:00:01 PM)

After market: 9.7 -0.1 (-1.02%)

9.8

-0.3 (-2.97%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)02-13 2025-02-13/amc
Earnings (Next)N/A N/A
Inst Owners85.04%
Inst Owner Change-0.48%
Ins Owners3.21%
Ins Owner Change-1.44%
Market Cap1.43B
Analysts77.89
Price Target10.97 (11.94%)
Short Float %4.53%
Short Ratio7.76
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)268.05%
Min EPS beat(2)49.54%
Max EPS beat(2)486.56%
EPS beat(4)3
Avg EPS beat(4)153.2%
Min EPS beat(4)-262.44%
Max EPS beat(4)486.56%
EPS beat(8)7
Avg EPS beat(8)165.55%
EPS beat(12)11
Avg EPS beat(12)121.44%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.06%
Min Revenue beat(2)-0.56%
Max Revenue beat(2)0.69%
Revenue beat(4)1
Avg Revenue beat(4)-0.68%
Min Revenue beat(4)-1.86%
Max Revenue beat(4)0.69%
Revenue beat(8)4
Avg Revenue beat(8)0.11%
Revenue beat(12)6
Avg Revenue beat(12)-0.01%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.61%
PT rev (3m)-12.2%
EPS NQ rev (1m)3.41%
EPS NQ rev (3m)3.41%
EPS NY rev (1m)1.45%
EPS NY rev (3m)1.45%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)-0.01%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 61.25
Fwd PE 22.64
P/S 1.82
P/FCF 37.36
P/OCF 26.96
P/B 7.24
P/tB 9.48
EV/EBITDA N/A
EPS(TTM)0.16
EY1.63%
EPS(NY)0.43
Fwd EY4.42%
FCF(TTM)0.26
FCFY2.68%
OCF(TTM)0.36
OCFY3.71%
SpS5.39
BVpS1.35
TBVpS1.03
PEG (NY)0.36
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.08%
ROE -43.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 62.54%
FCFM 4.87%
ROA(3y)-16.47%
ROA(5y)-17.55%
ROE(3y)-39.54%
ROE(5y)-143.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.88%
GM growth 5Y5.41%
F-Score7
Asset Turnover1.3
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 58.12%
Cap/Sales 1.88%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.27
Quick Ratio 1.27
Altman-Z 1.36
F-Score7
WACC10.67%
ROIC/WACCN/A
Cap/Depr(3y)61.78%
Cap/Depr(5y)87.15%
Cap/Sales(3y)2.06%
Cap/Sales(5y)2.62%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2305843009213694000%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%400%
EPS Next Y170.58%
EPS Next 2Y97.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7.92%
Revenue growth 3Y15.11%
Revenue growth 5Y23.27%
Sales Q2Q%5.48%
Revenue Next Year2.22%
Revenue Next 2Y4.21%
Revenue Next 3Y7.31%
Revenue Next 5Y9.34%
EBIT growth 1Y35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year468.16%
EBIT Next 3Y135.56%
EBIT Next 5Y105.98%
FCF growth 1Y353.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2745.54%
OCF growth 3YN/A
OCF growth 5YN/A